Aeda healthcare ramps up manufacturing capabilities with
expansion into Hong Kong headquarters
Hong Kong – November 2007.
Aeda Healthcare Ltd – a recent entrant to the
international healthcare market – has set its sights clearly on the future of
manufacturing excellence, today announcing the relocation of their
manufacturing headquarters from Taiwan to Hong Kong.
Originally a longer-term strategy, the move has been fast tracked in response to
strong demand for their product, and in recognition of the world-class capabilities
and efficiencies that China has to offer. With manufacturing facilities already
operating throughout China, the Company seized an early opportunity to
centralize their rapidly expanding production base, and so increase production
capacity and logistical control.
“Hong Kong is undoubtedly the premier logistics hub into China,” commented
Shane Swan, Product Development Manager for Aeda Healthcare, “and with the
rapid growth of China’s manufacturing prowess, it makes sense for our Head
Office to be strategically positioned in this critical gateway. The move is designed
not only to supplement our existing production capabilities but to establish us at
the forefront of leading technological development and manufacturing excellence
for the future”.
Although less than two years since Aeda launched their introductory product
range in the US – the Aeria series – the Company has already expanded it’s
manufacturing network into China ahead of forecast, and continues to invest in
development opportunities to deliver premium product at economical rates. The
relocation of the Head Office (encompassing R&D, Logistics and Warehousing)
into Hong Kong signals the Company’s commitment to the region and confidence
in their future growth.
|